You Didn't Save 14% on Your Medical Supply Contract. You Deferred the Bill.
2026-11-06 by Kenji Mori
The slide deck said 14%
Last quarter I sat through a procurement review where our team presented a 14% reduction in per-unit cost on the wound care and continence supply contract. There were charts. There was applause. Our director mentioned it in the monthly all-hands.
Six weeks later I was on the phone at 9 PM with a distributor, paying expedited freight on replacement stock because field staff were reporting adhesive failures at a rate I hadn't budgeted for.
That's when I stopped trusting the line-item savings column.
I manage procurement for a mid-sized health system—three long-term care sites, one acute care contract, and a supply budget I've been tracking line-by-line since 2018. I've negotiated with over 40 vendors. I've documented every order in our cost tracking system. And I still let a 14% slide deck convince me I'd done my job.
The cost we didn't put on the slide
I'm not going to pretend the savings were fake. The unit price really did drop 14%. But a unit price is not a cost. It's one input.
Over the next two quarters I pulled every incident log, every emergency PO, and every nursing-time complaint related to that contract. The effective cost—unit price plus additional dressing changes plus the two clinical consults triggered by the adhesive issues—was roughly 4% higher than the previous contract. We had moved 14% from the visible column to a column nobody was tracking.
Note to self: the invoice is not the cost.
Why we keep making this mistake
The "buy on unit price" instinct isn't stupid. It's just old.
This was rational 20 years ago when procurement meant tabulating three paper quotes and picking the lowest number, because that was the only data you had. Today we have order histories, incident logs, maintenance records, and usage data going back years. The data changed. The scorecards mostly didn't.
Most procurement KPIs still reward the person who moves the unit price down. Nobody gets promoted for avoiding a problem that doesn't show up in the price column. That's a structural incentive problem, not an intelligence problem.
The causation runs the other way
Here's the part that took me too long to internalize. We assume the cheaper vendor is cheaper because they're more efficient. Sometimes that's true. More often, it's the reverse: the vendor who delivers reliable quality can afford to hold their price, because they're not absorbing the cost of replacements, returns, and emergency shipments.
People think expensive vendors deliver better quality. Actually, vendors who deliver quality can charge more. The causation runs the other way.
The "cheap" quote is partly funded by the risk they're passing to you.
What it actually looked like in our logs
I want to be specific, because "look at TCO" is the kind of advice that sounds obvious and changes nothing. So here are the actual line items from our 2023–2024 fiscal year.
Wound care: the ConvaTec hydrocolloid dressing review
We ran our own reviews of ConvaTec hydrocolloid medical dressings against two lower-priced products for our long-term care accounts. The lower-priced products were about 18% less per dressing. Over 90 days our incident logs showed a higher rate of adhesive failure and leakage—which meant more changes per patient per week.
When I factored in the extra units, the additional nursing time, and the three wound-care consultations that got triggered, the effective cost per patient-week was about 9% higher than the ConvaTec product. The unit price metric said we saved money. The usage data said we didn't.
(I'm not saying the lower-priced products were defective. I'm saying our use case—long-term care, high-moisture wounds, rotating staff—didn't match what the pricing assumed. The mismatch landed on us.)
Skin barriers: the ConvaTec Sensi Care comparison
Same pattern with our ConvaTec Sensi Care review. Higher unit price. Lower reorder rate. Net: we spent less. The first time I saw that in the numbers I actually double-checked the spreadsheet, because it felt wrong.
Every cost analysis pointed to the budget option. My gut said something was off about their responsiveness during the demo. Turns out that "slow to reply" was a preview of "slow to replace."
ICU monitor refresh
We had a competing option that undercut the incumbent by about $2,300 per unit across a 12-bed expansion. Two units failed calibration within the first 8 months. Replacement sensors, service calls, and a temporary rental while we waited on parts ate most of the difference. I'm still not sure it was worth the staff frustration—and I definitely didn't enjoy explaining it to the department head.
Nebulizer machine fleet
Low stakes, right? We thought so too. The cheaper units were louder, and our respiratory therapists started requesting transfers. I lost a senior RT for two months of retraining on a different vendor's interface. That's a cost the quote sheet never shows.
Catheter ablation equipment
Even the catheter ablation suite—where our team had spent months answering basic questions like what catheter ablation actually involves before we could scope the equipment properly—fell into the same pattern. The clinical requirements came first, but the TCO analysis changed which vendor made the shortlist. The one with the lowest equipment invoice wasn't the one we picked.
Across these categories, our purchase-order records showed roughly $340,000 in wound care spending, $210,000 on monitor sensors and service, and $85,000 on nebulizer consumables for fiscal year 2023–2024. The unit-price approach looked good on every one of those lines. The TCO approach told a different story.
What I do now
I don't have a fancy framework. I have a spreadsheet with five columns, and every vendor quote has to fill them in before I sign anything.
- Unit price × realistic annual volume. Not the volume the vendor assumes. Ours, from actual usage logs.
- Hidden fees. Freight, setup, training, warranty exclusions. Read the exclusions. Then read them again.
- Replacement and return rate. From our incident logs, or from a documented trial if it's a new product.
- Staff time impact. Estimate it, then double it. I have never once overestimated this.
- Switching cost if this vendor fails. The number most people skip, because it requires imagining a future that hasn't happened yet.
Total it. Compare it. The lowest unit price rarely wins the total.
I started requiring this after a 2022 contract that I'd rather not relive in detail. It's not glamorous. It doesn't make a good slide deck. But it's the only column that reflects what actually leaves our budget.
To be fair, there's a real argument for the old way: it's fast, it's simple, and it's defensible in a budget meeting. I get why people stick with it. But "defensible in a meeting" and "accurate" are not the same thing.
The 14% slide deck from last quarter? That contract is up for renewal in eight months. I've already started the TCO comparison. This time the savings number will mean something.